# ORCL — Oracle · catalysts, narrative & risks

**Deep-research report — K3vl4r**  
**Symbols:** ORCL  
**Sources:** 20  
**Published:** 2026-09-08  
**Canonical:** https://app.k3vl4r.com/research/deep-research-orcl-oracle-catalysts-narrative-risks-798

---

# Oracle Corporation (ORCL) — Research Snapshot as of 2026-09-08

## Price Performance Context

The stock has experienced significant volatility. Per one research note, ORCL peaked near $346 in September 2025 and then fell into the ~$145 range by February 2026, with the decline attributed to a slightly-missed revenue print, aggressive capital-expenditure (capex) guidance, scrutiny over the "Stargate" project, and a securities class action lawsuit [[1]](https://phemex.com/academy/oracle-orcl-stock-2026). Analyst consensus was characterized as a "Moderate Buy" with a very wide target range of $130 to $400 [[1]](https://phemex.com/academy/oracle-orcl-stock-2026). 

A caveat worth flagging: the same note describes this as a "roughly 48%" decline [[1]](https://phemex.com/academy/oracle-orcl-stock-2026), but a move from $346 to $145 actually represents roughly a 58% drop, so the stated percentage appears inconsistent with the cited price points. More recently, Oracle closed at $142.07 on August 20, 2026, and the stock has fallen nearly 20% year-to-date in 2026 [[7]](https://robinhood.com/us/en/stocks/ORCL/), [[15]](https://www.tradingview.com/symbols/NYSE-ORCL/).

---

_Preview only. The complete multi-source deep-research report — full thesis, evidence, and citations — is available at https://app.k3vl4r.com/research/deep-research-orcl-oracle-catalysts-narrative-risks-798 (free to sign up)._